David J. Marguglio, SVP and Chief Business Officer at Adamis Pharmaceuticals Corp (ADMP), sold 11,859 shares at $0.60 ($7K) on 2022-03-18, disclosed to the SEC on 2022-03-22.
Scheduled sale ($7k) by SVP and Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ADMP | SELL | 2020-11-20 | $3K | — | Filing → |
| ADMP | SELL | 2020-10-01 | $16K | — | Filing → |
| ADMP | SELL | 2020-08-20 | $8K | — | Filing → |